MARSHALL WACE, LLP - TARO PHARMACEUTICAL INDS LTD ownership

TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 97 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q1 2015. The put-call ratio across all filers is 0.54 and the average weighting 1.4%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of TARO PHARMACEUTICAL INDS LTD
ValueSharesWeighting
Q4 2022$242,426
-11.8%
8,348
-9.1%
0.00%0.0%
Q3 2022$275,000
-26.5%
9,183
-11.4%
0.00%0.0%
Q2 2022$374,000
-33.8%
10,361
+12.3%
0.00%
-83.3%
Q1 2020$565,000
-81.0%
9,224
-76.6%
0.01%
-73.9%
Q3 2019$2,975,000
+334.3%
39,432
+392.0%
0.02%
+283.3%
Q2 2019$685,000
-50.3%
8,014
-42.8%
0.01%0.0%
Q3 2018$1,378,000
+66.2%
14,014
+142.2%
0.01%
-25.0%
Q1 2016$829,000
-83.1%
5,787
-81.8%
0.01%
-82.6%
Q4 2015$4,911,000
+16.7%
31,779
+7.9%
0.05%
-11.5%
Q3 2015$4,209,000
-36.8%
29,457
-36.5%
0.05%
-40.2%
Q2 2015$6,665,000
+27.6%
46,383
+25.3%
0.09%
+27.9%
Q1 2015$5,222,000
-63.7%
37,029
-61.8%
0.07%
-64.2%
Q4 2014$14,377,000
+182.1%
97,017
+192.9%
0.19%
+156.8%
Q3 2014$5,097,000
+226.9%
33,128
+198.0%
0.07%
+221.7%
Q2 2014$1,559,00011,1160.02%
Other shareholders
TARO PHARMACEUTICAL INDS LTD shareholders Q1 2015
NameSharesValueWeighting ↓
ISZO CAPITAL LP 1,104,068$104,886,00077.66%
Greywolf Capital Management LP 472,135$46,694,00010.17%
Consonance Capital Management LP 263,732$26,083,0004.28%
Moab Capital Partners 83,132$8,222,0003.77%
Raging Capital Management, LLC 190,151$18,806,0003.45%
Valentine Capital Asset Management, Inc. 145,053$14,346,0003.07%
Assured Investment Management LLC 1,353,342$133,846,0001.21%
Ativo Capital Management LLC 22,828$2,258,0000.99%
Perceptive Advisors 56,602$5,598,0000.67%
Jaffetilchin Investment Partners, LLC 7,721$764,0000.38%
View complete list of TARO PHARMACEUTICAL INDS LTD shareholders